IL1F10 and colitis: As shown in Figure 2A, IL-38 deficient mice displayed enhanced susceptibility to DSS colitis compared to WT mice, as demonstrated by significantly higher DAI scores at day 3 (P < 0.05) and days 5-9 (P < 0.0001).